Update on Psychopharmacology: A Contrarian (or Skeptical) View?
Psychopharmacology has revolutionized the treatment of psychiatric disorders in the last few decades. With newer psycho-pharmaco-therapeutic agents gaining attention related to efficacy and tolerability, their unpredictability can leave clinicians with an imprecise prescribing strategy. Dr. David M. Tobolowsky will discuss the names and indications for some of the newer psycho-pharmaco-therapeutic agents and appraise the scientific data to determine which patients to prescribe them to, taking into consideration the concerns, side effects and contraindications associated with these agents.
Primary Care Physicians, Family Practice Physicians, Emergency Medicine Physicians, Neurologists, Psychiatrists, Nurses, Advanced Practice Registered Nurses, Social Workers and other interested clinical care providers.
- Recognize the names and indications for some of the newer psycho-pharmaco-therapeutic agents.
- Describe concerns, side effects and contraindications associated with the use of psycho-pharmaco-therapeutic agents.
- Accurately identify which patients psycho-pharmaco-therapeutic agents may be indicated for.
David M. Tobolowsky, M.D.
Adult and Geriatric Psychiatrist
Board-certified in Psychiatry
David M. Tobolowsky, M.D., faculty for this educational activity, has no relevant financial relationships with ineligible companies* to disclose, and has indicated that the presentation or discussion will include off-label or unapproved product usage.
Barry M. Crown, Ph.D., conference director for this educational activity, has no relevant financial relationships with ineligible companies* to disclose.
Non-faculty contributors and others involved in the planning, development and editing/review of the content have no relevant financial relationships to disclose with ineligible companies.*
*Ineligible companies – Companies whose primary business is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients.
Baptist Health South Florida is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Baptist Health has been re-surveyed by the ACCME and awarded Commendation for 6 years as a provider of CME for physicians.
Baptist Health South Florida designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 1.25 AMA PRA Category 1 Credit™
- 1.25 General certificate of attendance
- 1.25 Florida Board of Clinical Social Workers, Marriage and Family Therapists and Mental Health Counselors
- 1.00 Nurse Practitioners
- 1.00 Florida Board of Nursing
This site is supported on the most recent stable releases of the following browsers:
This site is supported on the following mobile devices:
If you are experiencing technical difficulties or have received an error message, please send an email to CME@baptisthealth.net and include a print screen of the error message, your browser name and version, username and URL where the error occurred. You can expect a response within 48 hours.